Summary Rapid 7 is a leading cyber-security company with offerings historically addressing the SMB space. The company has a surprisingly modest valuation given its growth and opportunity set. It is ranked as a leader in the SIEM space but has more than a few other solutions appealing to both its historic SMB base and to…

To access this post, you must subscribe.

Read More

These are hard times for most of us, and hard times for security analysts as well. Not the kind of analyst who looks at your home or the data network you or your company use, but the kind that is supposed to recommend stocks. Most of the time analysts try to find new stocks to…

To access this post, you must subscribe.

Read More

Summary Pure Storage shares have been eviscerated or worse long before the advent of the upside down economics of the Covid-19 era. They have not seen a material bounce back since the March lows. The company has both outgrown its peers and has a dramatically greater gross margin than its competitors. The company has converted…

To access this post, you must subscribe.

Read More

On Thursday, the Raymond James FinTech analyst, John Davis, downgraded the shares of Square (SQ) to sell from hold And the Rosenblatt IT analyst, Yuri Kim downgraded Anaplan shares from buy to neutral.  And earlier today, Rod Hall of Goldman, Sachs downgraded many of the names on his coverage list including Nutanix. The GS downgrade…

To access this post, you must subscribe.

Read More

Summary Elastic shares are down more than 20% from the company’s post earning peak share price set on February 28th. That quarter was impressive with beats on revenues, earnings and other significant metrics. This company is a stealth competitor in the observability market, one of the hottest spaces in the IT firmament the last year…

To access this post, you must subscribe.

Read More

April showers bring May flowers. Of course in NYC, there are also April flowers, and this year, there were even flowers in March. It is a dark, windy, rainy day here, but life goes on. Livongo Health is a name I reviewed back in January before the virus was a prominent factor in stock selection.…

To access this post, you must subscribe.

Read More

Thursday’s price action has seen some consolidation in the IT sector after a halcyon performance on Wednesday. No more than anyone else, I have no idea if the bottom is in-I hope it is, and I have made my portfolio bets that way, but sentiment in the last few weeks has been like quicksilver. Sometimes…

To access this post, you must subscribe.

Read More

The news that most people watch is about the progress that has been made against the Covid-19 virus. Frankly, some of it seem ghoulish to me, and more like the plot for a Hollywood movie. I suppose today’s journalists and media imagine that this is what their audience wants to read and see. But in…

To access this post, you must subscribe.

Read More

Summary Last week Shopify withdrew its guidance and the shares plunged 10%. The shares are now down 35% from peak levels reached in the wake of a particularly strong Q4. The withdrawal of guidance is neither surprising or alarming-this company’s revenue base is derived from e-commerce sales that have likely declined along with employment and…

To access this post, you must subscribe.

Read More